These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3489824)

  • 1. Acetazolamide enhancement of HIPDM brain flow distribution imaging.
    Burt RW; Reddy RV; Mock BM; Wellman HN; Schauwecker DS; Witt R
    J Nucl Med; 1986 Oct; 27(10):1627-31. PubMed ID: 3489824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-isotope brain SPECT imaging with technetium-99m and iodine-123: clinical validation using xenon-133 SPECT.
    Devous MD; Payne JK; Lowe JL
    J Nucl Med; 1992 Nov; 33(11):1919-24. PubMed ID: 1432149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral blood flow tomography by single photon emission computerized tomography using 133Xe in cerebrovascular disease.
    Lassen NA; Rommer P
    Monogr Atheroscler; 1986; 14():71-82. PubMed ID: 3090430
    [No Abstract]   [Full Text] [Related]  

  • 4. Tomographic assessment of regional cerebral perfusion using intravenous I-123 HIPDM and a rotating gamma camera.
    Fazio F; Lenzi GL; Gerundini P; Collice M; Gilardi MC; Colombo R; Taddei G; Del Maschio A; Paicentini M; Kung HF
    J Comput Assist Tomogr; 1984 Oct; 8(5):911-21. PubMed ID: 6332124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral blood flow study by 133Xe inhalation and single photon emission CT in occlusive cerebrovascular diseases].
    Sakai Y; Kasuga T; Nakanishi F; Sone S; Maruyama A; Kawai T; Tanizaki Y; Kato S
    Kaku Igaku; 1987 Jan; 24(1):47-54. PubMed ID: 3494869
    [No Abstract]   [Full Text] [Related]  

  • 6. Temporal evolution of brain distribution of IMP and HIPDM. Concise communication.
    Moretti JL; Kung HF; Cesaro P; Blau M; Defer G; Holman L; Vigneron N; Rapin JR
    Nucl Med Commun; 1987 Jul; 8(7):597-602. PubMed ID: 3500438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive xenon-133 measurements of cerebral blood flow using stationary detectors compared with dynamic emission tomography.
    Schroeder T; Vorstrup S; Lassen NA; Engell HC
    J Cereb Blood Flow Metab; 1986 Dec; 6(6):739-46. PubMed ID: 3491828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [133Xe-DSPECT (Dynamic Single Photon Emission CT). Results of a new noninvasive method for measuring regional cerebral blood flow (rCBF). Comparison with cranial angiography and transmission CT].
    Büll U; Moser EA; Kirsch CM; Schmiedek P
    Rofo; 1983 Oct; 139(4):351-8. PubMed ID: 6413315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM.
    Leonard JP; Nowotnik DP; Neirinckx RD
    J Nucl Med; 1986 Dec; 27(12):1819-23. PubMed ID: 3491188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve.
    Rogg J; Rutigliano M; Yonas H; Johnson DW; Pentheny S; Latchaw RE
    AJR Am J Roentgenol; 1989 Sep; 153(3):605-12. PubMed ID: 2763961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-photon tomographic study of regional cerebral blood flow after stroke: concise communication.
    Bonte FJ; Stokely EM
    J Nucl Med; 1981 Dec; 22(12):1049-53. PubMed ID: 6975808
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional cerebral blood flow measurements in stroke: the necessity of a tomographic approach.
    Lassen NA
    J Cereb Blood Flow Metab; 1981; 1(2):141-2. PubMed ID: 6976974
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical cerebral blood flow thresholds studied by SPECT using xenon-133 and iodine-123 iodoamphetamine.
    Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
    J Nucl Med; 1989 Mar; 30(3):337-42. PubMed ID: 2786938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of regional cerebral blood flow (rCBF) in cerebrovascular disease using SPECT and N-isopropyl-p-[123I] iodoamphetamine (IMP): comparison with IMP hemispheric uptake count and mean CBF by 133Xe arterial infusion method].
    Seto H; Futatsuya R; Kamei T; Taki K; Kakishita M; Moto A; Endo T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Aug; 45(8):1135-41. PubMed ID: 3879348
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo quantitation of regional cerebral blood flow in glioma and cerebral infarction: validation of the HIPDm-SPECT method.
    Drayer B; Jaszczak R; Friedman A; Albright R; Kung H; Greer K; Lischko M; Petry N; Coleman E
    AJNR Am J Neuroradiol; 1983; 4(3):572-6. PubMed ID: 6410800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Computed tomographic measurement of the cerebral blood flow with xenon-133].
    Lassen NA; Steinling M
    Rev Prat; 1987 Feb; 37(11):613-21. PubMed ID: 3494296
    [No Abstract]   [Full Text] [Related]  

  • 17. 123I-Amphetamine single photon emission computed (SPECT) tomography versus 133Xe dynamic SPECT: preliminary results.
    Buell U; Olteanu-Nerbe V; Kirsch CM; Schmiedek P
    Nucl Med Commun; 1984 Jul; 5(7):439-49. PubMed ID: 6335743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stable xenon computed tomography. Methodology and clinical application].
    Haubitz B; Holl K; Becker H
    Radiologe; 1993 Nov; 33(11):620-5. PubMed ID: 8278588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional cerebral blood flow measured by xenon-133 and [123I]iodo-amphetamine in patients with cerebrovascular diseases.
    Henriksen L; Vorstrup S; Paulson OB
    Prog Brain Res; 1984; 62():245-52. PubMed ID: 6335918
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of two cerebral perfusion tracers, N-isopropyl I-123 p-iodoamphetamine and I-123 HIPDM, in the human.
    Holman BL; Lee RG; Hill TC; Lovett RD; Lister-James J
    J Nucl Med; 1984 Jan; 25(1):25-30. PubMed ID: 6610030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.